Share

January 24, 2017; 88 (4) Editorial

Understanding of the role of manganese in parkinsonism and Parkinson disease

Marcia H. Ratner, Edward Fitzgerald
First published December 28, 2016, DOI: https://doi.org/10.1212/WNL.0000000000003543
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
233

Share

Article Information

vol. 88 no. 4 338-339
DOI: 
https://doi.org/10.1212/WNL.0000000000003543
PubMed: 
28031391
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published December 28, 2016.

Article Versions

Copyright & Usage: 
© 2016 American Academy of Neurology

Author Disclosures

    1. Marcia H. Ratner, PhD and
    2. Edward Fitzgerald, PhD
  1. Marcia H. Ratner, PhD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Editorial Board Member, EC Pharmacology and Toxicology 2016

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Edward Fitzgerald, PhD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Institute of Environmental Health Sciences, R01ES022652, PI, 2014 - 2017

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Laboratory of Molecular Neurobiology (M.H.R.), Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, MA; and Department of Environmental Health Sciences (E.F.), School of Public Health, University at Albany, Rensselaer, NY.
  1. Correspondence to Dr. Ratner: marcia{at}bu.edu
View Full Text

Article usage

Article usage: December 2016 to February 2023

AbstractFullPdfSource
Dec 2016382010Highwire
Jan 201713134585Highwire
Feb 2017524821Highwire
Mar 201768108Highwire
Apr 201712415Highwire
May 20176346Highwire
Jun 20175214Highwire
Jul 20172920Highwire
Aug 20174124Highwire
Sep 20173633Highwire
Oct 20177321Highwire
Nov 20177702Highwire
Dec 20178124Highwire
Jan 20189405Highwire
Feb 20187511Highwire
Mar 20189312Highwire
Apr 201810865Highwire
May 20189321Highwire
Jun 20188810Highwire
Jul 20186411Highwire
Aug 20189822Highwire
Sep 20188412Highwire
Oct 20189611Highwire
Nov 20188512Highwire
Dec 20188803Highwire
Jan 201910034Highwire
Feb 20195265Highwire
Mar 20198021Highwire
Apr 20196763Highwire
May 20193211Highwire
Jun 20195710Highwire
Jul 20194001Highwire
Aug 20193911Highwire
Sep 20194412Highwire
Oct 20194111Highwire
Nov 20193510Highwire
Dec 20193421Highwire
Jan 20204910Highwire
Feb 20205364Highwire
Mar 20201811Highwire
Apr 20203704Highwire
May 20201703Highwire
Jun 20202500Highwire
Jul 20203700Highwire
Aug 20201902Highwire
Sep 20206210Highwire
Oct 20206400Highwire
Nov 20205610Highwire
Dec 20203620Highwire
Jan 20212411Highwire
Feb 20212900Highwire
Mar 20211801Highwire
Apr 20211200Highwire
May 20211412Highwire
Jun 20212400Highwire
Jul 20214031Highwire
Aug 20213500Highwire
Sep 20212801Highwire
Oct 20212400Highwire
Nov 20213801Highwire
Dec 20211800Highwire
Jan 20223000Highwire
Feb 20223301Highwire
Mar 20222900Highwire
Apr 20222510Highwire
May 20222700Highwire
Jun 20225903Highwire
Jul 20222524Highwire
Aug 20222300Highwire
Sep 20221101Highwire
Oct 20222101Highwire
Nov 20222600Highwire
Dec 20222802Highwire
Jan 20232032Highwire
Feb 20231710Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles